AllazoHealth Insights

Patient adherence has been a top priority in healthcare for quite some time now, but driving improvements looks different in recent years. New technologies and innovations have introduced a host of robust strategies to improve patient adherence to medication. Let’s… Read

Gaps in the healthcare system have a profound impact on patient outcomes, and not in a positive way. Poor care coordination and management can result in missed or delayed treatment, introduce dangerous patient safety concerns, increase healthcare spending, and ultimately… Read

In the ever-evolving healthcare industry, change is constant. The rise of value-based care and pay-for-performance programs is a prime example of such change. Pay-for-performance programs continue to gain momentum as a popular alternative to traditional healthcare payment models, and healthcare… Read

The COVID-19 pandemic has impacted just about every facet of our lives over the past two years. So much has changed, from how we interact socially to how we access healthcare and take our medications. So how exactly has the pandemic affected… Read

Pharmaceutical companies are increasingly investing in patient support programs designed to increase engagement, optimize medication use, and achieve better individual health outcomes. However, not all patient outreach is effective, and getting it right is essential to achieve the best possible… Read

Patient engagement is a hot topic in healthcare, and for very good reason. Engaged patients tend to make healthier lifestyle choices, adhere to care plans, and achieve positive overall health outcomes. Because patient engagement has been a top priority in healthcare… Read

Pharmacists are uniquely positioned to impact patient outcomes. Due to their accessibility and expertise, they play a key role in identifying and addressing gaps in care that can lead to negative (and even deadly) consequences for patients. Trust is also a… Read

Enter the era of value-based care. In recent years, rising healthcare costs have prompted a shift from fee-for-service payment models to pay-for-performance, or “value-based,” reimbursement. Alternative payment models have transformed healthcare as we know it, with more payers reimbursing care… Read

Rare diseases: although statistically uncommon, their burden is significant. Between 25 and 30 million Americans live with rare diseases. These diseases include cystic fibrosis, muscular dystrophy, sickle cell disease, hemophilia, and as many as 7,000 other rare conditions. Although research has… Read

Direct and indirect remuneration (DIR) contracts are diverse. However, they share one common feature: the expectation from payers and PBMs that a pharmacy network will increase its performance and strive for a higher percentile rank year to year. Therefore, retail… Read

Population health management (PHM) has emerged as a priority in healthcare in recent years. The shift from volume- to value-based care has prompted  payers to implement PHM strategies to control costs, boost quality performance, and improve patient outcomes. Many payers… Read